Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 213

1.

Identification of a conserved region of Plasmodium falciparum MSP3 targeted by biologically active antibodies to improve vaccine design.

Singh S, Soe S, Mejia JP, Roussilhon C, Theisen M, Corradin G, Druilhe P.

J Infect Dis. 2004 Sep 1;190(5):1010-8. Epub 2004 Jul 27.

PMID:
15295710
2.

A Plasmodium falciparum GLURP-MSP3 chimeric protein; expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies.

Theisen M, Soe S, Brunstedt K, Follmann F, Bredmose L, Israelsen H, Madsen SM, Druilhe P.

Vaccine. 2004 Mar 12;22(9-10):1188-98.

PMID:
15003647
3.

Merozoite surface protein-3: a malaria protein inducing antibodies that promote Plasmodium falciparum killing by cooperation with blood monocytes.

Oeuvray C, Bouharoun-Tayoun H, Gras-Masse H, Bottius E, Kaidoh T, Aikawa M, Filgueira MC, Tartar A, Druilhe P.

Blood. 1994 Sep 1;84(5):1594-602.

PMID:
8068948
4.

A conserved multi-gene family induces cross-reactive antibodies effective in defense against Plasmodium falciparum.

Singh S, Soe S, Weisman S, Barnwell JW, Pérignon JL, Druilhe P.

PLoS One. 2009;4(4):e5410. doi: 10.1371/journal.pone.0005410. Epub 2009 Apr 30.

5.

Pre-clinical assessment of novel multivalent MSP3 malaria vaccine constructs.

Bang G, Prieur E, Roussilhon C, Druilhe P.

PLoS One. 2011;6(12):e28165. doi: 10.1371/journal.pone.0028165. Epub 2011 Dec 1.

6.

Toward the rational design of a malaria vaccine construct using the MSP3 family as an example: contribution of immunogenicity studies in models.

Daher LJ, Demanga CG, Prieur E, Pérignon JL, Bouharoun-Tayoun H, Druilhe P.

Infect Immun. 2010 Jan;78(1):477-85. doi: 10.1128/IAI.00941-08. Epub 2009 Jul 6.

7.

Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.

Lalitha PV, Biswas S, Pillai CR, Saxena RK.

Vaccine. 2008 Aug 18;26(35):4526-35. doi: 10.1016/j.vaccine.2008.06.031. Epub 2008 Jun 30.

PMID:
18590786
8.

Plasmodium falciparum: further characterization of a functionally active region of the merozoite invasion ligand EBA-175.

Sim BK, Carter JM, Deal CD, Holland C, Haynes JD, Gross M.

Exp Parasitol. 1994 May;78(3):259-68.

PMID:
7512929
10.

Immunization with recombinant duffy binding-like-gamma3 induces pan-reactive and adhesion-blocking antibodies against placental chondroitin sulfate A-binding Plasmodium falciparum parasites.

Costa FT, Fusaï T, Parzy D, Sterkers Y, Torrentino M, Douki JB, Traoré B, Petres S, Scherf A, Gysin J.

J Infect Dis. 2003 Jul 1;188(1):153-64. Epub 2003 Jun 23.

PMID:
12825185
12.

The glutamate-rich protein (GLURP) of Plasmodium falciparum is a target for antibody-dependent monocyte-mediated inhibition of parasite growth in vitro.

Theisen M, Soe S, Oeuvray C, Thomas AW, Vuust J, Danielsen S, Jepsen S, Druilhe P.

Infect Immun. 1998 Jan;66(1):11-7.

13.

Naturally acquired antibodies to polymorphic and conserved epitopes of Plasmodium falciparum merozoite surface protein 3.

Osier FH, Polley SD, Mwangi T, Lowe B, Conway DJ, Marsh K.

Parasite Immunol. 2007 Aug;29(8):387-94.

14.

Allele specificity of naturally acquired antibody responses against Plasmodium falciparum apical membrane antigen 1.

Cortés A, Mellombo M, Masciantonio R, Murphy VJ, Reeder JC, Anders RF.

Infect Immun. 2005 Jan;73(1):422-30.

15.

Strain-specific humoral response to a polymorphic malaria vaccine.

Flück C, Smith T, Beck HP, Irion A, Betuela I, Alpers MP, Anders R, Saul A, Genton B, Felger I.

Infect Immun. 2004 Nov;72(11):6300-5.

16.

Passive transfer of Plasmodium falciparum MSP-2 pseudopeptide-induced antibodies efficiently controlled parasitemia in Plasmodium berghei-infected mice.

Martínez PA, Yandar N, Lesmes LP, Forero M, Pérez-Leal O, Patarroyo ME, Lozano JM.

Peptides. 2009 Feb;30(2):330-42. doi: 10.1016/j.peptides.2008.10.022. Epub 2008 Nov 21.

PMID:
19071172
17.

The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity.

Bongfen SE, Ntsama PM, Offner S, Smith T, Felger I, Tanner M, Alonso P, Nebie I, Romero JF, Silvie O, Torgler R, Corradin G.

Vaccine. 2009 Jan 7;27(2):328-35. doi: 10.1016/j.vaccine.2008.09.097. Epub 2008 Nov 5.

PMID:
18984024
18.

Allelic polymorphisms in apical membrane antigen-1 are responsible for evasion of antibody-mediated inhibition in Plasmodium falciparum.

Healer J, Murphy V, Hodder AN, Masciantonio R, Gemmill AW, Anders RF, Cowman AF, Batchelor A.

Mol Microbiol. 2004 Apr;52(1):159-68.

Supplemental Content

Support Center